Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung cancer immunotherapy: progress, pitfalls, and promises
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 476

Showing 1-25 of 476 citing articles:

Advances and challenges in the treatment of lung cancer
Yuting Li, Bingshuo Yan, Shiming He
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115891-115891
Open Access | Times Cited: 119
Long non-coding RNAs in lung cancer: Unraveling the molecular modulators of MAPK signaling
Md Sadique Hussain, Obaid Afzal, Gaurav Gupta, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154738-154738
Closed Access | Times Cited: 63
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
Ying Liu, Wei‐Qun Ding, Jianxun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer
Zhang Cai, Lijie Zhou, Mingyuan Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 21, pp. 3589-3601
Closed Access | Times Cited: 20
Recent advancement in the detection of potential cancer biomarkers using the nanomaterial integrated electrochemical sensing technique: a detailed review
Hema Bhardwaj, ARCHANA ARCHANA, Ashab Noumani, et al.
Materials Advances (2024) Vol. 5, Iss. 2, pp. 475-503
Open Access | Times Cited: 16
Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges
Yuchu Xiang, Xudong Liu, Yifan Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Monitoring ROS Responsive Fe3O4‐based Nanoparticle Mediated Ferroptosis and Immunotherapy via 129Xe MRI
Lei Zhang, Maosong Qiu, Ruifang Wang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 22
Closed Access | Times Cited: 13
Explainable Machine Learning to Predict Treatment Response in Advanced Non–Small Cell Lung Cancer
Vinayak S. Ahluwalia, Ravi B. Parikh
JCO Clinical Cancer Informatics (2025), Iss. 9
Closed Access | Times Cited: 1
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 1
Grade ≥ 3 hematologic adverse events of immunotherapy in advanced NSCLC patients: a systematic review and meta-analysis
Shuang Wang, Meng‐Ting Cai, Yajun Xiong, et al.
European Journal of Clinical Pharmacology (2025)
Closed Access | Times Cited: 1
Peptide‐Appended Nanosonosensitizers Targeting Tumor Glycolysis for Synergistic Sonodynamic–Immunometabolic Therapy of Spinal‐Metastasized Tumors
Ziyang Chen, Liang Chen, Yiqun Ma, et al.
Advanced Materials (2023) Vol. 35, Iss. 42
Closed Access | Times Cited: 35
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 26
A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches
David Amilo, Bilgen Kaymakamzade, Evren Hınçal
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
Ming Zhao, Zhi Guo, Yinghua Zou, et al.
Hepatology International (2023) Vol. 18, Iss. 1, pp. 4-31
Closed Access | Times Cited: 21
LC-MS/MS-assisted label-free SERS blood analysis by self-position plasmonic platform for tumor screening
Min Fan, Kaiming Peng, Youliang Weng, et al.
Chemical Engineering Journal (2024) Vol. 483, pp. 149348-149348
Closed Access | Times Cited: 12
Detection and quantification of microplastics in various types of human tumor tissues
Jun Zhao, Haibo Zhang, Lei Shi, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 283, pp. 116818-116818
Open Access | Times Cited: 10
Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinoma
Shengshan Xu, Xiguang Chen, Haoxuan Ying, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Cutting-Edge Therapies for Lung Cancer
Anita Silas La’ah, Shih‐Hwa Chiou
Cells (2024) Vol. 13, Iss. 5, pp. 436-436
Open Access | Times Cited: 9
Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer
Na Song, Kai Cui, Liqun Zeng, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176357-176357
Closed Access | Times Cited: 8
Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence
Jin Zhang, Yue Ma
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116909-116909
Open Access | Times Cited: 8
A Multistage‐Responsive Antibody‐Delivery Strategy to Improve Immunotherapy for NSCLC Brain Metastasis by Ultrasensitive Releasing and Tumor‐Anchoring
Shuaijun Li, Caiting Meng, Qian Hao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 17
Closed Access | Times Cited: 7
Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients
Wei Zhang, Ruiyue Dang, Hongyi Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Corynoxine triggers cell death via activating PP2A and regulating AKT-mTOR/GSK3β axes in NSCLC
Guoqing Hou, Weihua Hu, Ya-Zhou Sang, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116110-116110
Closed Access | Times Cited: 7
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
Jessica Konen, Haoyi Wu, Don L. Gibbons
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 520-536
Closed Access | Times Cited: 7
Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect
Conghua Lu, Ziyuan Gao, Di Wu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e009165-e009165
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top